SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle

Abstract MCT1 is a critical protein found in monocarboxylate transporters that plays a significant role in regulating the lactate shuttle. However, the post‐transcriptional modifications that regulate MCT1 are not clearly identified. In this study, it is reported that SETDB1 interacts with MCT1, lea...

Full description

Bibliographic Details
Main Authors: Xiaowei She, Qi Wu, Zejun Rao, Da Song, Changsheng Huang, Shengjie Feng, Anyi Liu, Lang Liu, Kairui Wan, Xun Li, Chengxin Yu, Cheng Qiu, Xuelai Luo, Junbo Hu, Guihua Wang, Feng Xu, Li Sun
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202301871
_version_ 1797663905240055808
author Xiaowei She
Qi Wu
Zejun Rao
Da Song
Changsheng Huang
Shengjie Feng
Anyi Liu
Lang Liu
Kairui Wan
Xun Li
Chengxin Yu
Cheng Qiu
Xuelai Luo
Junbo Hu
Guihua Wang
Feng Xu
Li Sun
author_facet Xiaowei She
Qi Wu
Zejun Rao
Da Song
Changsheng Huang
Shengjie Feng
Anyi Liu
Lang Liu
Kairui Wan
Xun Li
Chengxin Yu
Cheng Qiu
Xuelai Luo
Junbo Hu
Guihua Wang
Feng Xu
Li Sun
author_sort Xiaowei She
collection DOAJ
description Abstract MCT1 is a critical protein found in monocarboxylate transporters that plays a significant role in regulating the lactate shuttle. However, the post‐transcriptional modifications that regulate MCT1 are not clearly identified. In this study, it is reported that SETDB1 interacts with MCT1, leading to its stabilization. These findings reveal a novel post‐translational modification of MCT1, in which SETDB1 methylation occurs at K473 in vitro and in vivo. This methylation inhibits the interaction between MCT1 and Tollip, which blocks Tollip‐mediated autophagic degradation of MCT1. Furthermore, MCT1 K473 tri‐methylation promotes tumor glycolysis and M2‐like polarization of tumor‐associated macrophages in colorectal cancer (CRC), which enhances the lactate shuttle. In clinical studies, MCT1 K473 tri‐methylation is found to be upregulated and positively correlated with tumor progression and overall survival in CRC. This discovery suggests that SETDB1‐mediated tri‐methylation at K473 is a vital regulatory mechanism for lactate shuttle and tumor progression. Additionally, MCT1 K473 methylation may be a potential prognostic biomarker and promising therapeutic target for CRC.
first_indexed 2024-03-11T19:22:31Z
format Article
id doaj.art-dc07c14d17494bbab0d30599c1fb7309
institution Directory Open Access Journal
issn 2198-3844
language English
last_indexed 2024-03-11T19:22:31Z
publishDate 2023-10-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj.art-dc07c14d17494bbab0d30599c1fb73092023-10-07T03:51:49ZengWileyAdvanced Science2198-38442023-10-011028n/an/a10.1002/advs.202301871SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate ShuttleXiaowei She0Qi Wu1Zejun Rao2Da Song3Changsheng Huang4Shengjie Feng5Anyi Liu6Lang Liu7Kairui Wan8Xun Li9Chengxin Yu10Cheng Qiu11Xuelai Luo12Junbo Hu13Guihua Wang14Feng Xu15Li Sun16GI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaGI Cancer Research Institute Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaDepartment of Oncology Tongji Hospital Huazhong University of Science and Technology Wuhan 430030 P. R. ChinaAbstract MCT1 is a critical protein found in monocarboxylate transporters that plays a significant role in regulating the lactate shuttle. However, the post‐transcriptional modifications that regulate MCT1 are not clearly identified. In this study, it is reported that SETDB1 interacts with MCT1, leading to its stabilization. These findings reveal a novel post‐translational modification of MCT1, in which SETDB1 methylation occurs at K473 in vitro and in vivo. This methylation inhibits the interaction between MCT1 and Tollip, which blocks Tollip‐mediated autophagic degradation of MCT1. Furthermore, MCT1 K473 tri‐methylation promotes tumor glycolysis and M2‐like polarization of tumor‐associated macrophages in colorectal cancer (CRC), which enhances the lactate shuttle. In clinical studies, MCT1 K473 tri‐methylation is found to be upregulated and positively correlated with tumor progression and overall survival in CRC. This discovery suggests that SETDB1‐mediated tri‐methylation at K473 is a vital regulatory mechanism for lactate shuttle and tumor progression. Additionally, MCT1 K473 methylation may be a potential prognostic biomarker and promising therapeutic target for CRC.https://doi.org/10.1002/advs.202301871lactate shuttleMCT1 methylationSETDB1tumor progression
spellingShingle Xiaowei She
Qi Wu
Zejun Rao
Da Song
Changsheng Huang
Shengjie Feng
Anyi Liu
Lang Liu
Kairui Wan
Xun Li
Chengxin Yu
Cheng Qiu
Xuelai Luo
Junbo Hu
Guihua Wang
Feng Xu
Li Sun
SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle
Advanced Science
lactate shuttle
MCT1 methylation
SETDB1
tumor progression
title SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle
title_full SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle
title_fullStr SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle
title_full_unstemmed SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle
title_short SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle
title_sort setdb1 methylates mct1 promoting tumor progression by enhancing the lactate shuttle
topic lactate shuttle
MCT1 methylation
SETDB1
tumor progression
url https://doi.org/10.1002/advs.202301871
work_keys_str_mv AT xiaoweishe setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT qiwu setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT zejunrao setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT dasong setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT changshenghuang setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT shengjiefeng setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT anyiliu setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT langliu setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT kairuiwan setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT xunli setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT chengxinyu setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT chengqiu setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT xuelailuo setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT junbohu setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT guihuawang setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT fengxu setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle
AT lisun setdb1methylatesmct1promotingtumorprogressionbyenhancingthelactateshuttle